|Videos|November 18, 2020

Overlapping diseases and COVID-19's impact

Author(s)Brooke Henson, Editor, Tracy Schroeder Swartz, OD, MS, FAAO, Marguerite McDonald, MD

Episodes in this series

EP. 1 Introduction and overview

EP. 1 Introduction and overview

EP. 2 Consequences and epidemiology of untreated dry eye

EP. 2 Consequences and epidemiology of untreated dry eye

EP. 3 Diagnosis and overlooking asymptomatic patients with DED

EP. 3 Diagnosis and overlooking asymptomatic patients with DED

EP. 4 Standard testing and assessment for DED

EP. 4 Standard testing and assessment for DED

EP. 5 General Principles of Treatment of DED

EP. 5 General Principles of Treatment of DED

EP. 6 OD and MD communication for optimal care

EP. 6 OD and MD communication for optimal care

EP. 7 Review of artificial tears for DED

EP. 7 Review of artificial tears for DED

EP. 8 Corticosteroids and Immunomodulators for the treatment of dry eye

EP. 8 Corticosteroids and Immunomodulators for the treatment of dry eye

Eric Donnenfeld, MD, and Marguerite McDonald, MD, discuss the role of nutritional supplements as well as antibiotics in dry eye management.

EP. 9 The role of nutritional supplements and antibiotics in DED

Crystal Brimer, OD, FAAO, identifies the preferred treatment options for meibomian gland dysfunction.

EP. 10 How to treat meibomian gland dysfunction

Crystal Brimer, OD, FAAO, shares some in-office procedures for dry eye and the patient resistance with high cost.

EP. 11 In-office procedures and patient resistance for DED treatments

EP. 12 Treatments for aqueous dry eye

EP. 12 Treatments for aqueous dry eye

EP. 13 Challenges in the management of DED

EP. 13 Challenges in the management of DED

EP. 14 Counseling and formulary concerns for DED therapies

EP. 14 Counseling and formulary concerns for DED therapies

EP. 15 Overlapping diseases and COVID-19's impact

EP. 15 Overlapping diseases and COVID-19's impact

EP. 16 Agents in the pipeline for DED

EP. 16 Agents in the pipeline for DED

EP. 17 Novel agents in the pipeline for DED

EP. 17 Novel agents in the pipeline for DED

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related Content

Closeup of older woman's irritated eye Image credit: AdobeStock/Hector

Survey: Fewer than 1 in 7 women link dry eye to perimenopause or menopause

ByLucia Gambuzza

September 3rd 2026

Work productivity | Image Credit: Adobe Stock/Prostock-studio

Study: Tryptyr treatment associated with complex visual tasks improvement in DED patients

September 2nd 2026

Takeaways from this week in optometry | Image Credit: Canva

Takeaways from this week in optometry: August 24-28

August 29th 2026

Yehia Hashad, MD, executive vice president of research and development and chief medical officer at Bausch + Lomb (Credit: Bausch + Lomb)

Bausch + Lomb advances 2 first-in-class eye health therapies

August 25th 2026

Neel R. Desai, MD (Credit: The Eye Institute of West Florida)

FDA expands TearCare indication to improve meibomian gland function

August 24th 2026

Latest CME

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

In-Person + Virtual Event

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

September 13, 2026

EyeCon 2026

EyeCon 2026

September 26, 2026

Join Us at The Ophthalmology Meeting This October in New Orleans

In-Person + Virtual Event

Join Us at The Ophthalmology Meeting This October in New Orleans

October 9-11, 2026

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

The changing IPL landscape: How advances in light-based technology are reshaping the treatment of MGD

DOT spectacle lens wear count ascends to 2 million pairs worldwide

Survey: Fewer than 1 in 7 women link dry eye to perimenopause or menopause

Study: Tryptyr treatment associated with complex visual tasks improvement in DED patients

FDA grants De Novo nod to Avulux lens for migraine-associated photophobia